Trial Profile

Phase 1b Study of LY3295668 Erbumine Monotherapy in Patients With Platinum-Sensitive, Extensive-Stage Small-Cell Lung Cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 15 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AK 01 (Primary)
Indications Small cell lung cancer
Focus Pharmacokinetics; Therapeutic Use
Sponsors Eli Lilly and Company

Most Recent Events

02 Mar 2021 Status changed from active, no longer recruiting to completed.
17 Nov 2020 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
17 Jun 2020 Planned End Date changed from 15 Feb 2021 to 31 Dec 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com